MDM2 vs MDM4: dependency and drugs side by side
MDM2 vs MDM4 in DepMap 24q4 Chronos data and drug annotations: 384 of 1178 cell lines depend on MDM2, 142 on MDM4; 12 drugs listed for MDM2, 1 for MDM4.
Blog
Worked examples from BioQ: genes, drugs, trials, structures and papers searched across 97 bio databases — with the real results, the sources and the exact query to repeat.
MDM2 vs MDM4 in DepMap 24q4 Chronos data and drug annotations: 384 of 1178 cell lines depend on MDM2, 142 on MDM4; 12 drugs listed for MDM2, 1 for MDM4.
Tiratricol FDA approval (Emcitate): ChEMBL shows 68 targets, THRB and THRA top by pChEMBL, and 3 registered trials on ClinicalTrials.gov, as of 2026-11-17.
A CD4-based CAR-NK paper on HIV rebound, placed in context with BioQ data on CD4: DepMap dependency, Open Targets diseases, drugs and Reactome pathways.
Phase 2 trial NCT07470489 pairs zanzalintinib with cemiplimab in BRAF wild-type anaplastic thyroid cancer; ChEMBL, ClinicalTrials.gov and DepMap data inside.
A 2026 paper links GSTM1 loss to worse cisplatin kidney injury; BioQ shows what DepMap, Open Targets, ChEMBL, Reactome and STRING say about GSTM1 today.
NCT07877584 is a phase 3 NSCLC trial of PD-1 blockade with or without chemotherapy; BioQ adds carboplatin ChEMBL potency and ClinicalTrials.gov context.
A new FAERS paper on semaglutide and panic attacks, set against ChEMBL potency, ClinicalTrials.gov registrations and PubChem identity as of 2026-11-15.
Phase 1b/2 trial NCT07646821 adds ropeginterferon alfa-2b to azacitidine in TP53-mutated MDS/AML; ChEMBL, ClinicalTrials.gov and DepMap data as of 2026-11-15.
JAK2 vs TYK2 in DepMap and drug databases: 8 of 1178 cell lines are dependent on JAK2, 11 on TYK2; 47 drugs are known for JAK2 and 20 for TYK2.
A paper watch on Bacteroidetes and HCC immunotherapy resistance, with what DepMap, Open Targets, TCGA, CIViC and STRING show about MYC as of 2026-11-14.
NCT07821684 is a phase 3 trial in non-squamous NSCLC; we pair it with docetaxel potency in ChEMBL, 1628 registered trials and EGFR dependency in DepMap.
A Nature Chemical Biology paper on a TNKS2-selective inhibitor, set against DepMap, ChEMBL, Open Targets, Reactome and STRING data for TNKS2 as of 2026-11-13.